Scale Up & Tech Transfer

May 01, 2017
BioPharm International
Can bioprocessing runs be consistently replicated in an inherently variable production environment?
Mar 01, 2017
BioPharm International
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics
Jan 01, 2017
BioPharm International
There is much work to do to achieve efficient, cost-effective production processes.
Oct 15, 2016
BioPharm International
Classical production in cell-based systems such as mammalian and bacterial cells requires cell line development and lengthy process development to support scale-up. With plant technology, generic plant bioreactors can be grown rapidly and then transfected with a transient vector based system to produce proteins in days. Large-scale commercial facilities are now available in the US, enabling clinical or commercial production of significant quantities of therapeutic materials within a year.
Jul 14, 2016
This new method uses inter-alpha inhibitors to promote attachment and long-term growth in stem cells.
Jun 01, 2016
BioPharm International
Scale-up of complex, innovative products requires commercialization models that are sustainable.
May 31, 2016
BioPharm sat down with an intellectual property lawyer to examine how companies are protected when they engage in activities where sharing of trade secrets must occur.
Apr 01, 2016
BioPharm International
A modular cell-culture platform demonstrates accelerated process development.
Oct 29, 2015
By BioPharm International Editors
The novel antibody-engineering platform works differently than most of the currently employed antibody-modifying technologies, according to UM Baltimore.
Jul 01, 2015
BioPharm International Multimedia
By BioPharm International Editors
Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.
lorem ipsum